Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.69 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.69 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.69 |
| ▸ | TSHR | P16473 | 3/20 | 0.69 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.69 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.69 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.69 |
| ▸ | NPC1 | O15118 | 2/20 | 0.65 |
| ▸ | RAB9A | P51151 | 2/20 | 0.65 |
| ▸ | MAPT | P10636 | 1/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.65 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.58 |
| ▸ | SCN1A | P35498 | 2/20 | 0.58 |
| ▸ | SCN2A | Q99250 | 2/20 | 0.58 |
| ▸ | SCN3A | Q9NY46 | 2/20 | 0.58 |
| ▸ | GAA | P10253 | 2/20 | 0.58 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.58 |
| ▸ | HTR1A | P08908 | 1/20 | 0.58 |
| ▸ | DRD3 | P35462 | 1/20 | 0.58 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL11394506 | 0.89 | LMNA (0.61) | LMNACYP1A2CYP3A4TSHRCYP2C19 | |
| SCHEMBL13601336 | 0.85 | BCHE (0.52) | LMNACYP1A2CYP3A4TSHRCYP2C19 | |
| SCHEMBL48450 | 0.84 | LMNA (0.79) | LMNACYP1A2CYP3A4TSHRCYP2C19 | |
| SCHEMBL561945 | 0.84 | NPC1 (0.80) | LMNACYP1A2CYP3A4TSHRCYP2C19 | |
| SCHEMBL4464262 | 0.84 | BCHE (0.51) | LMNACYP1A2CYP3A4TSHRCYP2C19 | |
| SCHEMBL13601161 | 0.84 | BCHE (0.51) | LMNACYP1A2CYP3A4TSHRCYP2C19 | |
| SCHEMBL13601165 | 0.83 | TDP1 (0.70) | LMNACYP1A2TSHRCYP2C19ALDH1A1 | |
| SCHEMBL4329445 | 0.83 | NPC1 (0.83) | LMNACYP1A2CYP3A4TSHRCYP2C19 | |
| SCHEMBL4334904 | 0.83 | NPC1 (0.83) | LMNACYP1A2CYP3A4TSHRCYP2C19 | |
| Water SCHEMBL21160825 | 0.83 | LMNA (0.77) | LMNACYP1A2CYP3A4TSHRCYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9452425-B2 | Compositions containing ionic liquids and their uses, in particular in organic synthesis | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2016-09-27 | — | — | US | disclosed |
| US-9452425-B2 | Compositions containing ionic liquids and their uses, in particular in organic synthesis | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2016-09-27 | — | — | US | disclosed |
| US-20090326228-A1 | COMPOSITIONS CONTAINING IONIC LIQUIDS AND THEIR USES, IN PARTICULAR IN ORGANIC SYNTHESIS | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2009-12-31 | — | — | US | disclosed |
| US-20090326228-A1 | COMPOSITIONS CONTAINING IONIC LIQUIDS AND THEIR USES, IN PARTICULAR IN ORGANIC SYNTHESIS | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2009-12-31 | — | — | US | disclosed |
| US-20060128996-A1 | Compositions containing Ionic liquids and uses thereof, especially in organic synthesis | UNIVERSITE DE RENNES 1 (FR) | 2006-06-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060128996-A1 | Compositions containing Ionic liquids and uses thereof, especially in organic synthesis | F12, ANXA1, OLA1 | LMNA 197/4885CYP1A2 782/4885CYP3A4 1763/4885 |
| US-20090326228-A1 | COMPOSITIONS CONTAINING IONIC LIQUIDS AND THEIR USES, IN PARTICULAR IN ORGANIC SYNTHESIS | F12, ANXA1, F11 | LMNA 110/4885CYP1A2 952/4885CYP3A4 2104/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.